World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
40864
World Ranking
15863
National Ranking
7982

Overview

James E. Balow is affiliated with the National Institutes of Health in the United States. Their research work spans multiple fields related to medicine and molecular biology. The primary areas of study include Rheumatology, Molecular Biology, Pathology and Forensic Medicine, Cell Biology, and Public Health, Environmental and Occupational Health.

Their main fields of study cover Medicine and Biochemistry, Genetics, and Molecular Biology. The scientific topics addressed in their publications involve Systemic Lupus Erythematosus Research, Inflammasome and immune disorders, Streptococcal Infections and Treatments, Osteomyelitis and Bone Disorders Research, Renal Diseases and Glomerulopathies, Liver Diseases and Immunity, and Immunodeficiency and Autoimmune Disorders.

James E. Balow has contributed to several notable research papers, including:

  • De novoCIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin-associated autoinflammatory diseases (2020, UNC Libraries)
  • Update on scoring and providing evidence basis for assessing pathology in lupus nephritis (2023, Kidney International)
  • Parathyroid Hormone Resistance and Autoantibodies to the PTH1 Receptor (2021, New England Journal of Medicine)
  • The classification of glomerulonephritis in systemic lupus erythematosus revisited (2021, UNC Libraries)
  • A novel variant affecting the cytoplasmic tail of the FAT1 protocadherin causing coloboma and renal failure: A case report (2023, Ophthalmic Genetics)

The scientist frequently collaborates with others in their field. Some of the regular co-authors include Sergio D. Rosenzweig, Surya V. Seshan, Agnes B. Fogo, Ivona Aksentijevich, and Miroslawa Nowak.

James E. Balow's research is published primarily in venues such as UNC Libraries, Kidney International, New England Journal of Medicine, and Ophthalmic Genetics. These publications reflect a focus on both clinical and molecular aspects of autoimmune and inflammatory diseases.

Best Publications

  • The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited

    Jan J. Weening;Vivette D. D'Agati;Melvin M. Schwartz;Surya V. Seshan

  • Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever

    I. Aksentijevich;M. Centola;Z. M. Deng;R. Sood

  • Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.

    H. A. Austin;J. H. Klippel;J. E. Balow;N. G.H. Le Riche

  • Enzyme replacement therapy in Fabry disease: a randomized controlled trial.

    Raphael Schiffmann;Jeffrey B. Kopp;Howard A. Austin;Sharda Sabnis

  • Glucocorticosteroid Therapy: Mechanisms of Action and Clinical Considerations

    Anthony S. Fauci;David C. Dale;James E. Balow

  • Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates

    Dimitrios T. Boumpas;George P. Chrousos;Ronald L. Wilder;Thomas R. Cupps

  • Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium.

    N Zaks;JE Balow;E Mansfield;M. E. Mangelsdorf

  • Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

    D.T. Boumpas;H.A. Austin;J.E. Balow;E.M. Vaughan

  • Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome.

    Howard A. Austin;Larry R. Muenz;Kathleen M. Joyce;Tatiana T. Antonovych

  • De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.

    Ivona Aksentijevich;Miroslawa Nowak;Mustapha Mallah;Jae Jin Chae

  • Prognostic factors in lupus nephritis. Contribution of renal histologic data

    Howard A. Austin;Larry R. Muenz;Kathleen M. Joyce;Tatiana A. Antonovych

  • Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis : A randomized, controlled trial

    Mark F. Gourley;Howard A. Austin;Dorothy Scott;Cheryl H. Yarboro

  • A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.

    Dimitrios T. Boumpas;Richard Furie;Susan Manzi;Gabor G. Illei

  • Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study

    Gabor G. Illei;Yuko Shirota;Cheryl H. Yarboro;Jimmy Daruwalla

  • Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

    Gabor G. Illei;Howard A. Austin;Marianna Crane;Lee Collins

  • Risk for Sustained Amenorrhea in Patients with Systemic Lupus Erythematosus Receiving Intermittent Pulse Cyclophosphamide Therapy

    Dimitrios T. Boumpas;Howard A. Austin;Ellen M. Vaughan;Cheryl H. Yarboro

  • Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course.

    Mary H Branton;Raphael Schiffmann;Sharda G Sabnis;Gary J Murray

  • Acute tumor lysis syndrome: A review of 37 patients with Burkitt's lymphoma

    Lawrence F. Cohen;James E. Balow;Ian T. Magrath;David G. Poplack

  • Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histologic data

    Howard A. Austin;Dimitrios T. Boumpas;Ellen M. Vaughan;James E. Balow

  • Methylprednisolone and Cyclophosphamide, Alone or in Combination, in Patients with Lupus Nephritis

    Mark F. Gourley;Howard A. Austin;Dorothy Scott;Cheryl H. Yarboro

Frequent Co-Authors

George C. Tsokos
George C. Tsokos Harvard Medical School
Dimitrios T. Boumpas
Dimitrios T. Boumpas National and Kapodistrian University of Athens
Gabor G. Illei
Gabor G. Illei Horizon Therapeutics
Alfred D. Steinberg
Alfred D. Steinberg Mitre (United States)
Anthony S. Fauci
Anthony S. Fauci Georgetown University
Daniel L. Kastner
Daniel L. Kastner National Institutes of Health
Ivona Aksentijevich
Ivona Aksentijevich National Institutes of Health
Michael D. Lockshin
Michael D. Lockshin Cornell University
Paul H. Plotz
Paul H. Plotz National Institutes of Health
Elon Pras
Elon Pras Tel Aviv University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While a traditional medical degree remains the main path to becoming a physician in the USA, many students explore related online healthcare degrees for greater flexibility and affordability. Online nursing programs, in particular, have become popular among those aiming to join the healthcare workforce or advance their current roles.

For those seeking to become advanced practice nurses, the cheapest nurse practitioner programs offer a cost-effective route, delivering rigorous training with remote learning options. If you're interested in leadership or specialized nursing roles, pursuing one of the cheapest online msn programs is a smart investment in your future.

Ambitious nurses looking to reach the highest educational level should consider the cheapest dnp programs, which focus on clinical expertise and advanced research skills. Additionally, working RNs aiming to complete their bachelor’s degree without breaking the bank can benefit from cheap rn to bsn online programs.

Exploring these pathways can open doors to diverse healthcare careers while managing costs and scheduling demands, making them ideal choices for many students planning a future in medicine or allied health.

Best Scientists Citing James E. Balow

Trending Scientists

Recently Published Articles